Democratic Lawmakers Demand Drugmakers Disclose MFN Deal Details
Congressional Democrats, including Reps. Frank Pallone Jr., Richard Neal, Bobby Scott and Sen. Ron Wyden, are demanding pharmaceutical companies disclose un-redacted details of their "most favored nation" drug pricing agreements with the Trump administration, according to a source familiar with the effort. If companies cannot provide the details, for example due to potential non-disclosure agreements with the White House, they were told to meet with lawmakers within two weeks to discuss how they will fulfill the request. The same four lawmakers sent a similar letter in March that the administration did not answer. Lawmakers want to know what drug companies are receiving in exchange for agreeing to lower prices for Medicaid, and to verify administration claims about savings to the public.